Treating patients post-stroke is an incredibly delicate balancing act. After clots block blood flow to the brain to cause the ...

Modern biomedical research depends on the ability to see what is happening inside biological tissue. Among the available ...

In peer-reviewed study on mice, Technion scientists say novel method using harmless microneedle patches opens the door to ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and biotechnology industries think about drug development, regenerative medicine, ...

In a highly collaborative, cross-institutional ImPLANT project funded by the Advanced Research Projects Agency for Health (ARPA-H) Personalized Regenerative Immunocompetent Nanotechnology Tissue ...

Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect BiosystemsAspect will ...

Biomacromolecules are increasingly important for treating major diseases such as tumors, infections, cardiovascular diseases, metabolic disorders, ...

Liver failure is one of the most serious and deadly medical conditions, claiming thousands of lives each year as patients in ...

The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...

In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair ...

Doctors say baldness as a result of chemotherapy-induced alopecia causes personal, social and professional anxiety.

The University of Brighton’s much-anticipated public lecture series returns this Spring.